| P50 | author | Xiaoyong Wang | Q56451884 |
| P2093 | author name string | Zijian Guo | |
| P2860 | cites work | Cellular processing of platinum anticancer drugs | Q29617899 |
| | Synthesis, characterization, cytotoxic activity, and cellular accumulation of dinuclear platinum complexes derived from N,N'-di-(2-aminoethyl)-1,3-diamino-2-propanol, aryl substituted N-benzyl-1,4-butanediamines, and N-benzyl-1,6-hexanediamines. | Q30805608 |
| | A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity. | Q31104149 |
| | Dinuclear alkyldiamine platinum antitumor compounds: a structure-activity relationship study. | Q31916996 |
| | Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. | Q33187848 |
| | Clinical perspectives on platinum resistance | Q33948747 |
| | Cisplatin resistance and oncogenes--a review | Q33970695 |
| | Endogenous carriers and ligands in non-immunogenic site-specific drug delivery | Q34019876 |
| | Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro | Q34047176 |
| | Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy | Q34086270 |
| | Current and future potential roles of the platinum drugs in the treatment of ovarian cancer | Q34430476 |
| | Encapsulation of platinum anticancer drugs by apoferritin. | Q34663714 |
| | Gold derivatives for the treatment of cancer | Q34671602 |
| | Molecular aspects of resistance to antitumor platinum drugs. | Q34866688 |
| | New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. | Q34914365 |
| | Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance | Q35083535 |
| | Toxicity of platinum compounds | Q35143947 |
| | Platinum-based anticancer agents: innovative design strategies and biological perspectives. | Q35146744 |
| | New metal complexes as potential therapeutics | Q35206943 |
| | Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation | Q35972641 |
| | Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches | Q36230304 |
| | Polymer therapeutics: concepts and applications | Q36380938 |
| | Metal-based antitumour drugs in the post genomic era. | Q36446191 |
| | Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin | Q36483034 |
| | Direct cellular responses to platinum-induced DNA damage | Q36800400 |
| | Basis for design and development of platinum(IV) anticancer complexes | Q36865704 |
| | Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53. | Q38302471 |
| | Effects of monofunctional platinum binding on the thermal stability and conformation of a self-complementary 22-mer | Q38306971 |
| | Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. | Q38344650 |
| | Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro. | Q40177156 |
| | A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts. | Q40213112 |
| | Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands | Q40238048 |
| | A positively charged trinuclear 3N-chelated monofunctional platinum complex with high DNA affinity and potent cytotoxicity. | Q40262351 |
| | DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects | Q40269665 |
| | Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties | Q40286973 |
| | Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties | Q40310092 |
| | Gold(III) compounds of 1,4,7-triazacyclononane showing high cytotoxicity against A-549 and HCT-116 tumor cell lines | Q40317824 |
| | Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug | Q40351646 |
| | Mechanisms of cytotoxicity of selected organogold(III) compounds | Q40362715 |
| | Adapter protein for site-specific conjugation of payloads for targeted drug delivery | Q40515922 |
| | Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. | Q40554384 |
| | Cytotoxic activity of metal complexes of biogenic polyamines: polynuclear platinum(II) chelates | Q40556803 |
| | New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. | Q40662840 |
| | 5-Fluorouracil-cisplatin adducts with potential antitumor activity. | Q40666128 |
| | A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole. | Q40736205 |
| | Further studies on the site-specific protein modification by microbial transglutaminase | Q40779928 |
| | Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety | Q40798829 |
| | Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis. | Q40814510 |
| | Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds | Q40853299 |
| | Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu). | Q40893138 |
| | Molecular recognition of metal complexes by DNA: a comparative study of the interactions of the parent complexes [PtCl(TERPY)]Cl and [AuCl(TERPY)]Cl2 with double stranded DNA. | Q43075438 |
| | Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA. | Q43503297 |
| | DNA targeted platinum complexes: synthesis, cytotoxicity and DNA interactions of cis-dichloroplatinum(II) complexes tethered to phenazine-1-carboxamides | Q43507474 |
| | cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro. | Q43643253 |
| | Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells. | Q43683418 |
| | A rare example of three abundant conformers in one retro model of the cisplatin-DNA d(GpG) intrastrand cross link. Unambiguous evidence that guanine O6 to carrier amine ligand hydrogen bonding is not important. possible effect of the Lippard base pa | Q43741178 |
| | Hydrolysis theory for cisplatin and its analogues based on density functional studies | Q43741184 |
| | MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA. | Q43797701 |
| | Design of macromolecular prodrug of cisplatin using dextran with branched galactose units as targeting moieties to hepatoma cells | Q43800374 |
| | Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore | Q43812059 |
| | Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance. | Q43821272 |
| | Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells. | Q43922040 |
| | Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties | Q43946320 |
| | Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity | Q43977115 |
| | Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents | Q43977118 |
| | Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates | Q44068264 |
| | DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair | Q44133887 |
| | Cytotoxic acridinylthiourea and its platinum conjugate produce enzyme-mediated DNA strand breaks | Q44148584 |
| | Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds | Q44384840 |
| | Monofunctional platinum complexes showing potent cytotoxicity against human liver carcinoma cell line BEL-7402. | Q44523317 |
| | Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy | Q44569860 |
| | Toward the design of novel polynuclear platinum antitumor complexes: a polydentate ligand system based on dipyridylamine and 1,3,5-trimethylenebenzene | Q44583166 |
| | Novel polynuclear platinum adducts detected during the reactions of [Pt(Met-S,N)Cl2] with gamma-glutathione and L-cysteine | Q44889638 |
| | A surprisingly stable macrochelate formed from the reaction of cis dinuclear platinum antitumor compounds with reduced glutathione | Q44910091 |
| | Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions | Q45086214 |
| | Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes | Q45294464 |
| | Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity. | Q46372854 |
| | Disulfide bond cleavage induced by a platinum(II) methionine complex | Q46648006 |
| | In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents. | Q47256953 |
| | Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin. | Q47321464 |
| | Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats | Q47795700 |
| | Nucleotide excision repair from site-specifically platinum-modified nucleosomes. | Q51836720 |
| | [Special qualities of inorganic cytostatics. Medicinal chemistry of platinum complexes]. | Q52933781 |
| | Synthesis, crystal structure, spectral properties and cytotoxic activity of platinum(II) complexes of 2-acetyl pyridine and pyridine-2-carbaldehyde N(4)-ethyl-thiosemicarbazones. | Q54047840 |
| | Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species | Q57240250 |
| | Antitumor active monofunctional platinum(II) complexes: Synthesis, structural characterization and reactivity towards biomolecules | Q57360980 |
| | Reactions of gold(III) complexes with serum albumin | Q58859001 |
| | Interactions of Selected Gold(III) Complexes with Calf Thymus DNA | Q58859019 |
| | Crystal structure and solution chemistry of the cytotoxic complex 1,2-dichloro(o-phenanthroline)gold(III) chloride | Q58859036 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1521-1532 | |
| P577 | publication date | 2007-12-04 | |
| P1433 | published in | Dalton Transactions | Q282900 |
| P1476 | title | Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents | |